Lexicon Pharmaceuticals Inventory

Lexicon Pharmaceuticals (LXRX) currently reports a inventory of $280K as of March 2026. That compares with $200K in the prior-year period — up 37.3% year over year. Use the charts on this page to explore Lexicon Pharmaceuticals's inventory history and peer comparisons.

Lexicon Pharmaceuticals's inventory increased from $200K to $280K — a 37.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lexicon Pharmaceuticals reported $280K in inventory as of March 2026. That compares with $200K in the prior-year period — up 37.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $280K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lexicon Pharmaceuticals, and consider following LXRX for alerts when major investors trade the stock.

Lexicon Pharmaceuticals is classified in the Healthcare sector. On inventory, it currently shows $280K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LXRX with unrelated industries.